Gavi Board approves $1.8 billion for African vaccine manufacturing and pandemic preparedness
Gavi, the Vaccine Alliance, has approved the establishment of the African Vaccine Manufacturing Accelerator (AVMA), which will provide up to $1 billion to support sustainable vaccine manufacturing in Africa. The Board also approved a $500 million First Response Fund to ensure immediate financing for future pandemic responses, as well as funding to help countries close routine immunization gaps caused by the COVID-19 pandemic. Additionally, the Board approved the inclusion of a new multivalent meningococcal vaccine in Gavi's portfolio and confirmed a shortlist of new vaccines for Gavi's next Vaccine Investment Strategy. France and Africa CDC will co-host a high-level event in June 2024 to officially launch AVMA and Gavi's investment case for its next replenishment.
- More than US$ 1.8 billion in support for African vaccine manufacturing, catching up missed children and pandemic preparedness approved as Gavi Board steps up efforts to tackle backsliding and fight health emergencies Gavi, the Vaccine Alliance
- New $1 billion plan for African vaccine manufacturing -GAVI Alliance Reuters
- Africa must take control of its vaccine manufacturing to protect against a new pandemic The Telegraph
Reading Insights
0
11
8 min
vs 9 min read
93%
1,631 → 115 words
Want the full story? Read the original article
Read on Gavi, the Vaccine Alliance